Xuan Gu Bao·2025-06-09 11:12Group 1 - Institutional trading saw 32 stocks listed, with 18 experiencing net buying and 14 net selling [1] - The top three stocks with the highest institutional buying were: Kuaijingtong (2.28 billion), Changshan Pharmaceutical (1.72 billion), and Rejing Bio (1.1 billion) [1][2] - Kuaijingtong's annual report indicates it has incubated early cross-border e-commerce DTC brands and maintains a significant position in the domestic cross-border e-commerce industry [3] Group 2 - The Ministry of Commerce announced that it will review export license applications for rare earths, with a gradual issuance of domestic export licenses expected to impact international prices [3] - The report from Guotai Junan Securities suggests that the recent export controls on rare earths may lead to a mismatch in supply and demand as overseas prices rise [3] - The report from Caitong Securities highlights a clear industrial trend for Chinese innovative drugs to expand globally, with an expected increase in drug applications in the U.S. over the next three years [3]